At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 120 enrolled
Drug / intervention
Diphenhydramine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of Diphenhydramine as an Adjunctive Sedative for Colonoscopy in Patients Chronically on Opioids
In Brief
A Phase 4 clinical trial evaluating Diphenhydramine and Placebo for Colonoscopy and Adjunct Anesthesia Medication. Completed, enrolled 120 participants across 1 site.
Detailed Summary
To access the efficacy of adding diphenhydramine as adjunct to improve sedation and to reduce the amount of standard sedatives used during colonoscopy in patients on chronic opioids.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy, Adjunct Anesthesia Medication
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 2013
Enrollment StartDec 2013
Primary CompletionMar 2018
Study CompletionJul 2018
TodayJul 2026
First PostedOct 22, 2013
Enrollment StartDec 1, 2013
Primary CompletionMar 1, 2018
Study CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 12.7 years ago
Interventions
Diphenhydraminedrug
Placebodrug